Pb2+ inhibition of sympathetic α7-nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilation in porcine basilar arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 3, 2003, Pages 1124-1131

  Si, Min Liang ^a   Lee, Tony Jer Fu ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BETA 2 ADRENERGIC RECEPTOR; BUNGAROTOXIN RECEPTOR; CADMIUM; CHOLINE; ISOPRENALINE; LEAD; NICOTINE; NICOTINIC RECEPTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ZINC ION; ALPHA-BUNGAROTOXIN RECEPTOR; CALCIUM; NICOTINIC RECEPTOR BLOCKING AGENT; PERTUSSIS TOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BLOOD VESSEL INNERVATION; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HYPERTENSION; IC 50; LONG TERM EXPOSURE; MALE; NITRERGIC NERVE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; SWINE; SYMPATHETIC NERVE; VASOCONSTRICTION; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; HISTOLOGY; IN VITRO STUDY; METABOLISM; NERVE CELL; PHYSIOLOGY; VASODILATATION;

ANIMALS; BASILAR ARTERY; BRAIN; CALCIUM; CELLS, CULTURED; CHOLINE; DRUG INTERACTIONS; FEMALE; ISOPROTERENOL; LEAD; MALE; NEURONS; NICOTINE; NICOTINIC ANTAGONISTS; NITROPRUSSIDE; PERTUSSIS TOXIN; RECEPTORS, NICOTINIC; SWINE; VASODILATION;

EID: 0037799812     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.046854     Document Type: Article

References (49)

1. Bost L, Primatesta P, Dong W, and Poulter N (1999) Blood lead and blood pressure: evidence from the Health Survey for England 1995. J Hum Hypertens 13:123-128.
2. Braun W and Gutjahr L (1971) Lead encephalopathy with intracranial pressure elevation in adults. Zentralbl Neurochir 32:167-172.
3. Brewer GJ (1997) Isolation and culture of adult rat hippocampal neurons. J Neurosci Methods 71:143-155.
4. Carmignani M, Boscolo P, Poma A, and Volpe AR (1999) Kininergic system and arterial hypertension following chronic exposure to inorganic lead. Immunophar-macology 44:105-110.
5. Carmignani M, Volpe AR, Boscolo P, Qiao N, Di Gioacchino M, Grilli A, and Felaco M (2000) Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sci 68:401-415.
6. Chang HR, Chen SS, Tsao DA, Cheng JT, Ho CK, and Yu HS (1997) Change of cardiac β-adrenoceptors in lead-exposed rats. Toxicology 123:27-32.
7. Chen SM, Swilley S, Bell R, Rajanna S, Reddy SL, and Rajanna B (2000) Lead induced alterations in nitrite and nitrate levels in different regions of the rat brain. Comp Biochem Physiol C Toxicol Pharmacol 125:315-323.
8. Cooper GP and Steinberg D (1977) Effects of cadmium and lead on adrenergic neuromuscular transmission in the rabbit. Am J Physiol 232:C128-C131.
9. Fleming WW, Westfall DP, De La Lande IS, and Jellett LB (1972) Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 181:339-345.
10. Gonick HC, Ding Y, Bondy SC, Ni Z, and Vaziri ND (1997) Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492.
11. Gulya K, Rakonczay Z, and Kasa P (1990) Cholinotoxic effects of aluminum in rat brain. J Neurochem 54:1020-1026.
12. Harlan WR(1988) The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect 78:9-13.
13. Holecyova A and Torok J (1990) The effect of cadmium on neuromuscular transmission in rabbit blood vessels. Bratisl Lek Listy 91:839-843.
14. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, and Gruetter CA (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749.
15. Jiang F, Li CG, and Rand MJ (1997) Mechanisms of electrical field stimulation-induced vasodilatation in the guinea-pig basilar artery: the role of endothelium. J Auton Pharmacol 17:71-76.
16. Khalil-Manesh F, Gonick HC, Weiler EW, Prins B, Weber MA, and Purdy RE (1993) Lead-induced hypertension: possible role of endothelial factors. Am J Hypertens 6:723-729.
17. Lai CC, Lin HH, Chen CW, Chen SH, and Chiu TH (2002) Excitatory action of lead on rat sympathetic preganglionic neurons in vitro and in vivo. Life Sci 71:1035-1045.
18. Lee TJF (1994) Putative transmitters in cerebral neurogenic vasodilation, in The Human Brain Circulation (Bevan RD and Bevan JA eds) pp 73-91, Humana Press, Totowa, NJ.
19. Lee TJF, Su C, and Bevan JA (1976) Neurogenic sympathetic vasoconstriction of the rabbit basilar artery. Circ Res 39:120-126.
20. 2-adrenoceptors mediate nicotine-induced NOergic dilation in porcine basilar arteries. Am J Physiol 279: H808-H816.
21. 2+ channels in cultured rat sphenopalatine ganglion neurons: an immunohistochemical and electrophysiological study. J Cereb Blood Flow Metab 20:183-191.
22. Luoma PV, Nayha S, Pyy L, and Hassi J (1995) Association of blood cadmium to the area of residence and hypertensive disease in Arctic Finland. Sci Total Environ 160-161:571-575.
23. Marques M, Millas I, Jimenez A, Garcia-Colis E, Rodriguez-Feo JA, Velasco S, Barrientos A, Casado S, and Lopez-Farre A (2001) Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J Am Soc Nephrol 12:2594-2600.
24. Mike A, Pereira EF, and Albuquerque EX (2000) Ca(2+)-sensitive inhibition by Pb(2+) of α7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res 873:112-123.
25. Okamura T, Ayajiki K, Uchiyama M, Uehara M, and Toda N (1999) Neurogenic vasodilatation of canine isolated small labial arteries. J Pharmacol Exp Ther 288:1031-1036.
26. Oortgiesen M, van Kleef RG, and Vijverberg HP (1997) Dual, non-competitive interaction of lead with neuronal nicotinic acetylcholine receptors in N1E-115 neuroblastoma cells. Brain Res 747:1-8.
27. 2+ on wild and mutant neuronal α7 nicotinic receptors. Proc Natl Acad Sci USA 95:10246-10250.
28. Pocock SJ, Shaper AG, Ashby D, Delves HT, and Clayton BE (1988) The relationship between blood lead, blood pressure, stroke and heart attacks in middle-aged British men. Environ Health Perspect 78:23-30.
29. Purdy RE, Smith JR, Ding Y, Oveisi F, Vaziri ND, and Gonick HC (1997) Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am J Hypertens 10:997-1003.
30. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443.
31. Schwartz J (1995) Lead, blood pressure and cardiovascular disease in men. Arch Environ Health 50:31-37.
32. Shelkovnikov SA and Gonick HC (2001) Influence of lead on rat thoracic aorta contraction and relaxation. Am J Hypertens 14:873-878.
33. Shiraki H, Kawasaki H, Tezuka S, Nakatsuma A, and Kurosaki Y (2000) Endogenous calcitonin gene-related peptide (CGRP) mediates adrenergic-dependent vasodilation induced by nicotine in mesenteric resistance arteries of the rat. Br J Pharmacol 130:1083-1091.
34. Si ML and Lee TJ (2001) Presynaptic α7-nicotinic acetylcholine receptors mediate nicotine-induced nitric oxidergic neurogenic vasodilation in porcine basilar arteries. J Pharmacol Exp Ther 298:122-128.
35. Si ML and Lee TJ (2002) α7-Nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation. Circ Res 91:62-69.
36. Struzynska L, Walski M, Gadamski R, Dabrowska-Bouta B, and Rafalowska U (1997) Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol Chem Neuropathol 31:207-224.
37. Teo JG, Goh KY, Ahuja A, Ng HK, and Poon WS (1997) Intracranial vascular calcifications, glioblastoma multiforme and lead poisoning. Am J Neuroradiol 18:576-579.
38. Toda N, Ayajiki K, and Okamura T (1997) Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries. J Physiol (Lond) 498:453-461.
39. Toda N and Okamura T (1998) Cerebral vasodilators. Jpn J Pharmacol 76:349-367.
40. Tsao DA, Yu HS, Cheng JT, Ho CK, and Chang HR (2000) Alterations in β-adrenergic receptor density and adenylate cyclase activity in the rat brain treated chronically with lead. Toxicology 146:93-99.
41. Uchiyama M, Okamura T, Uehara M, and Toda N (1997) Analysis of the vasodilator nerve function by nicotine in isolated dog skin artery. Eur J Pharmacol 321:19-25.
42. Varner JA, Jensen KF, Horvath W, and Isaacson RL (1998) Chronic administration of aluminum-fluoride or sodium-fluoride to rats in drinking water: alterations in neuronal and cerebrovascular integrity. Brain Res 784:284-298.
43. Vaziri ND and Ding Y (2001) Effect of lead on nitric oxide synthase expression in coronary endothelial cells: role of superoxide. Hypertension 37:223-226.
44. Weaver J, Porasuphatana S, Tsai P, Cao GL, Budzichowski TA, Roman LJ, and Rosen GM (2002) The activation of neuronal nitric-oxide synthase by various divalent cations. J Pharmacol Exp Ther 302:781-786.
45. Webb RC, Winquist RJ, Victery W, and Vander AJ (1981) In vivo and in vitro effects of lead on vascular reactivity in rats. Am J Physiol 241:H211-H216.
46. Zhang W, Edvinsson L, and Lee TJF (1998) Mechanism of nicotine-induced neurogenic vasodilation in the porcine basilar artery. J Pharmacol Exp Ther 284:790-797.
47. Zhao YJ, Yang GY, and Domino EF (1996) Zinc protoporphyrin, zinc ion and protoporphyrin reduce focal cerebral ischemia. Stroke 27:2299-2303.
48. 2+. Eur J Pharmacol 291:399-406.
49. 2+ on neuronal nicotinic acetylcholine receptors. Neurotoxicology 18:709-917.